Relapsed/Refractory Myeloma: Navigating the Complex Treatment Landscape

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Navigating the Complex Treatment Landscape in Relapsed/Refractory Myeloma

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
CAR T-Cells and Bispecific Antibodies in MM

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
ExpressPoints:Navigating the Complex Treatment Landscape in Relapsed/Refractory Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Experts Answer Pressing Questions on Recent Advances in Treatment of Relapsed/Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Advances in Relapsed/Refractory Myeloma: Keeping Pace With a Rapidly Evolving Treatment Landscape

Content Format:

Multimedia

Credit Type:

AMA

Credits:

2.00
CAR T Cells and Investigational Bispecific Antibodies in MM

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Expert Answers to HCP Questions on CAR T-Cell Therapy

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Podcast Pearls: Expert Answers to HCP Questions on CAR T-Cell Therapy

Content Format:

PDF

Credit Type:

--

Credits:

--
An Interactive Algorithm Tool: Assessment and Management of CAR T-Cell Toxicities

Content Format:

Tool

Credit Type:

--

Credits:

--
Current and Emerging CAR T-Cell Therapies in Cancer Care

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
ExpressPoints: Current and Emerging CAR T-Cell Therapies in Cancer Care

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CAR T-Cell Therapies for Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Adding Idecabtagene Vicleucel to the Treatment Armamentarium for Relapsed/Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
CAR T-Cell Therapy: Changing the Treatment Landscape for Hematologic Malignancies

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.00
Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Podcast Pearls: Expert Answers to HCP Questions on CAR T-Cell Therapies in Myeloma and Management of Key Toxicities

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
ExpressPoints: CAR T-Cell Therapy: Changing the Treatment Landscape for Hematologic Malignancies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CAR T-Cell Therapy: Changing the Treatment Landscape for Hematologic Malignancies

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
ExpressPoints: CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
A Fresh Look at CAR T-Cell Therapy: Recent Advances, New Evidence, and Evolving Paradigms to Improve Patient Care

Content Format:

Multimedia

Credit Type:

AMA

Credits:

1.75
Emerging CAR T-Cell Therapies in Myeloma and Management of Key Toxicities

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
CAR T-Cell Therapy: Applying the Data, Tailoring Treatment, and Future Considerations

Content Format:

Video

Credit Type:

AMA

Credits:

1.50
ExpressPoints: CAR T-Cell Therapy: Applying the Data, Tailoring Treatment, and Future Considerations

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
CAR T-Cell Therapy for Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Identifying and Managing CAR T-Cell–Mediated Toxicities

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Novel Approaches for Targeting BCMA in Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Why I’m Excited About Targeting BCMA in Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
What’s New With CAR T-Cell Therapies for Relapsed/Refractory Multiple Myeloma

Content Format:

Clinical Thought

Credit Type:

ACPE | AMA | ANCC

Credits:

0.25
Integrating the Latest Therapeutic Advances to Optimize the Care of Patients With Multiple Myeloma

Content Format:

Slideset Download

Credit Type:

--

Credits:

--
Integrating the Latest Therapeutic Advances to Optimize the Care of Veterans With Multiple Myeloma

Content Format:

PDF

Credit Type:

--

Credits:

--